Seiko Hirono
Papers
2
Total Citations
16
H-Index
2
About
Dr. Seiko Hirono is a leading surgical oncologist whose research centers on minimally invasive pancreatic surgery and perioperative complications. Her most impactful work addresses the critical question of oncologic safety in minimally invasive distal pancreatectomy (MIDP) for pancreatic cancer. As a key investigator in the Japan Clinical Oncology Group, Dr. Hirono co-authored the landmark multi-institutional randomized phase III trial (JCOG2202/LAPAN study, 2024, 9 citations), which directly compares MIDP—including laparoscopic and robotic approaches—against open distal pancreatectomy. This study is pivotal in providing rigorous evidence on short-term outcomes and oncologic equivalence, addressing a major gap in surgical practice. Additionally, her retrospective analysis of subcutaneous emphysema during laparoscopic and robotic abdominal surgery (2024, 7 citations) offers valuable insights into patient safety and complication management. Through these contributions, Dr. Hirono is shaping evidence-based guidelines for minimally invasive pancreatic surgery, balancing technical innovation with rigorous oncologic principles. Her work is essential reading for surgeons and researchers seeking to understand the evolving landscape of pancreatic cancer treatment and the safe adoption of advanced surgical technologies.
Research Focus
Key Achievements
Top Papers
- 1
- 2